Funding stagnant across the board
Canadian health R&D remains largely unchanged for fifth year running: StatsCan
Stagnant health R&D funding has stretched into its fifth year as turmoil in the pharmaceutical sector and unwillingness by governments to boost contribution levels continue to take their toll, according to the latest data from Statistics Canada.
Other stories mentioning these organizations, people and topics
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.